메뉴 건너뛰기




Volumn 18, Issue 1 A, 1998, Pages 91-95

Effects of c-MYC oncogene modulation on differentiation of human small cell lung carcinoma cell lines

Author keywords

Antisense; C myc; Cis diamminedichloroplatmum(II) (cisplatin); Differentiation; Drug resistance

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA1 INTEGRIN; CD15 ANTIGEN; CELL ADHESION MOLECULE; CYTOKERATIN; DEXAMETHASONE; MESSENGER RNA; MYC PROTEIN; VIMENTIN;

EID: 0031921501     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (25)
  • 1
    • 0027571473 scopus 로고
    • Small cell lung cancer: Etiology, biology, clinical features, staging, and treatment
    • Cook RM, Miller YE and Bunn PA Jr: Small cell lung cancer: etiology, biology, clinical features, staging, and treatment. Current Problems in Cancer XVII: 71-141, 1993.
    • (1993) Current Problems in Cancer , vol.17 , pp. 71-141
    • Cook, R.M.1    Miller, Y.E.2    Bunn Jr., P.A.3
  • 2
    • 0002173310 scopus 로고
    • Neuroendocrine (NE) tumors of the lung
    • Gazdar AF and Carbone DP, eds. Austin/Georgetown, R.G. Landes Company
    • Gazdar AF and Carbone DP: Neuroendocrine (NE) tumors of the lung. In: The biology and molecular genetics of lung cancer (Gazdar AF and Carbone DP, eds). Austin/Georgetown, R.G. Landes Company, pp 16-26, 1994.
    • (1994) The Biology and Molecular Genetics of Lung Cancer , pp. 16-26
    • Gazdar, A.F.1    Carbone, D.P.2
  • 3
    • 0027331858 scopus 로고
    • The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types
    • Prins J, De Vries EGE and Mulder NH: The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types. Anticancer Res 13: 1373-1386, 1993.
    • (1993) Anticancer Res , vol.13 , pp. 1373-1386
    • Prins, J.1    De Vries, E.G.E.2    Mulder, N.H.3
  • 4
    • 0023020262 scopus 로고
    • The myc oncogene: Its role in transformation and differentiation
    • Cole MD: The myc oncogene: its role in transformation and differentiation. Ann Rev Genet 20: 361-384, 1986.
    • (1986) Ann Rev Genet , vol.20 , pp. 361-384
    • Cole, M.D.1
  • 5
    • 0026705929 scopus 로고
    • Max and c-Myc/Max DNA-binding activities in cell extracts
    • Littlewood TD, Amati B, Land H and Evan GI: Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7: 1783-1792, 1992.
    • (1992) Oncogene , vol.7 , pp. 1783-1792
    • Littlewood, T.D.1    Amati, B.2    Land, H.3    Evan, G.I.4
  • 6
    • 0026688162 scopus 로고
    • Apoptotic cell death induced by c-myc is inhibited by bc1-2
    • Bissonnette RP, Echeverri F, Mahboubi A and Green DR: Apoptotic cell death induced by c-myc is inhibited by bc1-2. Nature 359: 552-554, 1992.
    • (1992) Nature , vol.359 , pp. 552-554
    • Bissonnette, R.P.1    Echeverri, F.2    Mahboubi, A.3    Green, D.R.4
  • 7
    • 0025730938 scopus 로고
    • Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc
    • Sklar MD and Prochownik EV: Modulation of cis-platinum resistance in Friend erythroleukemia cells by c-myc. Cancer Res 51: 2118-2123, 1991.
    • (1991) Cancer Res , vol.51 , pp. 2118-2123
    • Sklar, M.D.1    Prochownik, E.V.2
  • 11
    • 0002651205 scopus 로고
    • Monoclonal antibodies in clinical and experimental pathology of lung cancer
    • Ruiter DJ, Fleuren GJ and Warnaar SO, eds. Dordrecht, Boston, Lancaster, Martinus Nijhoff Publishers
    • De Leij L, Broers J, Ramaekers F, Berendsen H and Wagenaar Sj Sc: Monoclonal antibodies in clinical and experimental pathology of lung cancer. In: Application of monoclonal antibodies in tumour pathology (Ruiter DJ, Fleuren GJ and Warnaar SO, eds). Dordrecht, Boston, Lancaster, Martinus Nijhoff Publishers, pp 190-210, 1986.
    • (1986) Application of Monoclonal Antibodies in Tumour Pathology , pp. 190-210
    • De Leij, L.1    Broers, J.2    Ramaekers, F.3    Berendsen, H.4    Wagenaar, Sj.Sc.5
  • 13
    • 0025353691 scopus 로고
    • Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance
    • Andrews PA and Howell SB: Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35-43, 1990.
    • (1990) Cancer Cells , vol.2 , pp. 35-43
    • Andrews, P.A.1    Howell, S.B.2
  • 14
    • 0027120232 scopus 로고
    • P-Glycoprotein and resistance to anticancer drugs
    • Ling V: P-Glycoprotein and resistance to anticancer drugs. Cancer 69: 2603-2609, 1992,
    • (1992) Cancer , vol.69 , pp. 2603-2609
    • Ling, V.1
  • 16
    • 0025569131 scopus 로고
    • The role of detoxifying systems in resistance of tumour cells to cisplatin and adriamycin. A review
    • Meijer C, Mulder NH and De Vries EGE: The role of detoxifying systems in resistance of tumour cells to cisplatin and adriamycin. A review. Cancer Treat Rev 17: 389-407, 1990.
    • (1990) Cancer Treat Rev , vol.17 , pp. 389-407
    • Meijer, C.1    Mulder, N.H.2    De Vries, E.G.E.3
  • 17
    • 0025162113 scopus 로고
    • Reduced DNA topoisomerase II activity in an adriamycin-resistant human small cell lung carcinoma cell line
    • De Jong S, Zijlstra JG, De Vries EGE and Mulder NH: Reduced DNA topoisomerase II activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 50: 304-309, 1990.
    • (1990) Cancer Res , vol.50 , pp. 304-309
    • De Jong, S.1    Zijlstra, J.G.2    De Vries, E.G.E.3    Mulder, N.H.4
  • 18
    • 0021053735 scopus 로고
    • Amplification and expression of the c-myc oncogene in human lung cancer cell lines
    • Little CD, Bau MM, Carney DN, Gazdar AF and Minna JD: Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306: 194-196, 1983.
    • (1983) Nature , vol.306 , pp. 194-196
    • Little, C.D.1    Bau, M.M.2    Carney, D.N.3    Gazdar, A.F.4    Minna, J.D.5
  • 20
    • 0029064674 scopus 로고
    • Biological and molecular prognostic factors - Impact on treatment of patients with non-small cell lung cancer
    • Johnson BE: Biological and molecular prognostic factors - impact on treatment of patients with non-small cell lung cancer. Chest 107 (6 Suppl): 287S-290S, 1995.
    • (1995) Chest , vol.107 , Issue.6 SUPPL.
    • Johnson, B.E.1
  • 21
    • 0021611174 scopus 로고
    • Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors
    • Miettinen M, Lehto V-P and Virtanen I: Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors. Ultrastructural Pathology 7: 83-107, 1984.
    • (1984) Ultrastructural Pathology , vol.7 , pp. 83-107
    • Miettinen, M.1    Lehto, V.-P.2    Virtanen, I.3
  • 22
    • 0028901404 scopus 로고
    • Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin
    • Conforti G, Codegoni AM, Scanziani E, Dolfini E, Dasdia T, Calza M, Caniatti M and Broggini M: Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin. Br J Cancer 71: 505-511, 1995.
    • (1995) Br J Cancer , vol.71 , pp. 505-511
    • Conforti, G.1    Codegoni, A.M.2    Scanziani, E.3    Dolfini, E.4    Dasdia, T.5    Calza, M.6    Caniatti, M.7    Broggini, M.8
  • 23
    • 0026503479 scopus 로고
    • Heat-resistant variants of the Chinese hamster ovary cell: Alteration of cellular structure and expression of vimentin
    • Lee YJ, Hou ZZ, Curetty L, Armour EP, Saadi A, Bernstein J and Corry PM: Heat-resistant variants of the Chinese hamster ovary cell: alteration of cellular structure and expression of vimentin. J Cell Physiol 151: 138-146, 1992.
    • (1992) J Cell Physiol , vol.151 , pp. 138-146
    • Lee, Y.J.1    Hou, Z.Z.2    Curetty, L.3    Armour, E.P.4    Saadi, A.5    Bernstein, J.6    Corry, P.M.7
  • 24
    • 0025907505 scopus 로고
    • Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: Induction of vimentin gene expression
    • Rius C, Zorrilla AR, Cabanas C, Mata F, Bernabeu C and Aller P: Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: induction of vimentin gene expression. Mol Pharmacol 39: 442-448, 1991.
    • (1991) Mol Pharmacol , vol.39 , pp. 442-448
    • Rius, C.1    Zorrilla, A.R.2    Cabanas, C.3    Mata, F.4    Bernabeu, C.5    Aller, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.